Futura Medical plc FUM
LSE · United Kingdom · Health Technology
GBp 0.2200+0.02 (+11.68%)
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Incanthera PLC (AQSE:INC) has signed its first recurring revenue deal, supplying skincare creams to LED device maker iSmart Developments. It's a big step as the company shifts away from direct-to-consumer sales. Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) has struck a deal with Mexico's largest private hospital network to pilot its Steriwave infection treatment. Trials showed a 40% drop in post-surgical infections. Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF, FRA:RR1) has moved its Uberaba project in Brazil into pre-feasibility work with Mosaic. Early economics already show a $916 million net p
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare company behind the erectile dysfunction gel Eroxon, has increased the size of its retail share offer after strong demand from investors. The retail offer closed on Friday, having attracted applications well beyond the...
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the sexual health group behind the Eroxon erectile dysfunction gel, has begun a formal process that could see the sale of the business, or its assets. The move comes alongside a placing and subscription to raise approximately £1.6 million,...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.